{{Rsnum
|rsid=12071951
|Chromosome=1
|position=96648359
|Orientation=plus
|GMAF=0.2805
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 4.4 | 30.1 | 65.5
| HCB | 0.0 | 38.7 | 61.3
| JPT | 3.5 | 40.7 | 55.8
| YRI | 30.8 | 53.4 | 15.8
| ASW | 24.6 | 52.6 | 22.8
| CHB | 0.0 | 38.7 | 61.3
| CHD | 7.3 | 30.3 | 62.4
| GIH | 4.0 | 33.7 | 62.4
| LWK | 28.2 | 43.6 | 28.2
| MEX | 3.4 | 31.0 | 65.5
| MKK | 28.2 | 46.2 | 25.6
| TSI | 4.9 | 41.2 | 53.9
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22688191
|Trait=None
|Title=Genome-wide association study in a Swedish population yields support for greater CNV and MHC involvement in schizophrenia compared with bipolar disorder.
|RiskAllele=
|Pval=5E-7
|OR=1.1400
|ORtxt=None
|OA=1
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}